极端规模下的高通量结合亲和力计算
High-throughput Binding Affinity Calculations at Extreme Scales
摘要:
对化疗和分子靶向治疗的耐药性是限制癌症治疗有效性的主要因素。在许多情况下,耐药性可能与靶蛋白的遗传变化有关,无论是预先存在的还是在治疗过程中进化选择的。克服这一挑战的关键是了解药物结合的分子决定因素。使用分子模拟的多级管道,我们可以深入了解配体的结合自由能和停留时间,这可以为分层和个人治疗方案和药物开发提供信息。为了支持高性能计算资源上的绑定自由能的可扩展、自适应和自动化计算,我们引入了高吞吐量绑定亲和力计算器(HTBAC)。HTBAC使用构建块的方法,以获得工作流的灵活性和性能。我们展示了接近完美的弱缩放到数百个并发的多阶段绑定亲和力计算管道。这允许一个快速的时间解决方案,基本上是不变的计算协议,候选配体的大小和合奏模拟的数量。因此,HTBAC推进了结合亲和力计算和方案的技术水平。
英文摘要:
Resistance to chemotherapy and molecularly targeted therapies is a major factor in limiting the effectiveness of cancer treatment. In many cases, resistance can be linked to genetic changes in target proteins, either pre-existing or evolutionarily selected during treatment. Key to overcoming this challenge is an understanding of the molecular determinants of drug binding. Using multi-stage pipelines of molecular simulations we can gain insights into the binding free energy and the residence time of a ligand, which can inform both stratified and personal treatment regimes and drug development. To support the scalable, adaptive and automated calculation of the binding free energy on high-performance computing resources, we introduce the High- throughput Binding Affinity Calculator (HTBAC). HTBAC uses a building block approach in order to attain both workflow flexibility and performance. We demonstrate close to perfect weak scaling to hundreds of concurrent multi-stage binding affinity calculation pipelines. This permits a rapid time-to-solution that is essentially invariant of the calculation protocol, size of candidate ligands and number of ensemble simulations. As such, HTBAC advances the state of the art of binding affinity calculations and protocols.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。